Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous to Oral Antibiotic Switch Therapy for Probable Neonatal Bacterial Infections: Clinical Efficacy, Safety and Cost-effectiveness

NCT03247920 is registered in ClinicalTrials.gov with Franciscus Gasthuis as lead sponsor.

NCT NCT03247920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03247920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous to Oral Antibiotic Switch Therapy for Probable Neonatal Bacterial Infections: Clinical Efficacy, Safety and Cost-effectiveness
Lead sponsor
Franciscus Gasthuis
Phase
Phase 4
Overall status
Completed
Start date
November 4, 2017
Completion date
July 15, 2021
Enrollment
510 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal infection, neonatal sepsis